Most Read Articles
6 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
3 days ago
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
17 Aug 2019
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
19 Aug 2019
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.

Albumin-bilirubin score predicts HCC occurrence after DAA treatment

02 Jun 2019

The albumin-bilirubin (ALBI) score, along with platelet count and aspartate aminotransferase-lymphocyte ratio (ALRI) index, is an effective and simple tool for identifying patients at risk of developing hepatocellular carcinoma (HCC) after treatment with direct-acting antivirals (DAA), a new study has found.

Researchers performed a retrospective cohort study including 514 cirrhosis patients scheduled for treatment with DAAs. Aside from ALBI score and ALRI index, baseline variables collected included neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII) and platelet-to-lymphocyte ratio (PLR).

Of the study participants, 416 did not have a previous diagnosis of HCC (median age at the start of therapy, 63.3 years; 58.2 percent male) while 98 did (median age at the start of therapy, 71.0 years; 61.2 percent male). The median follow-up time was 18.04 months.

Multivariable Cox regression analysis showed that ALBI score (hazard ratio [HR], 2.35, 95 percent CI, 1.05–5.25; p=0.038) and platelet count (HR, 0.92, 0.85–1.00; p=0.048) were both significantly and independently associated with the risk of HCC occurrence.

The cumulative hazards of HCC occurrence at 6, 12 and 18 months were 0.010, 0.050 and 0.072, respectively.

In comparison, ALRI index was the only pertinent factor for HCC recurrence in participants with a history of HCC (HR, 1.05; 1.01–1.09; p=0.007). In this group of patients, the cumulative hazards of recurrence at 6, 12 and 18 months were 0.074, 0.261 and 0.380, respectively.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Hepatology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
6 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
3 days ago
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
17 Aug 2019
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
19 Aug 2019
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.